Valuation: Danaher Corporation

Market Cap 142B 124B 115B 105B 200B 13,694B 203B 1,370B 538B 6,687B 534B 522B 23,087B P/E 2026 *
32.5x
P/E 2027 * 26.8x
Enterprise Value 164B 144B 133B 122B 231B 15,824B 235B 1,583B 622B 7,727B 617B 603B 26,678B EV / Sales 2026 *
6.29x
EV / Sales 2027 * 5.52x
Free-Float
71.14%
Yield 2026 *
0.71%
Yield 2027 * 0.76%
1 day+1.17%
1 week+3.57%
Current month+6.56%
1 month+11.93%
3 months+4.75%
6 months-13.99%
Current year-11.33%
1 week 195.05
Extreme 195.05
205.28
1 month 174.22
Extreme 174.2162
205.28
Current year 160.93
Extreme 160.93
242.8
1 year 160.93
Extreme 160.93
242.8
3 years 160.93
Extreme 160.93
281.7
5 years 160.93
Extreme 160.93
333.96
10 years 75.71
Extreme 75.71
333.96
Manager TitleAgeSince
Chief Executive Officer 62 31/08/2020
Director of Finance/CFO - 27/02/2026
Chief Tech/Sci/R&D Officer - 24/08/2025
Director TitleAgeSince
Director/Board Member 74 30/06/1999
Chairman 74 31/12/1983
Director/Board Member 69 31/12/1983
Date Insider Type Main position Quantity % Market Cap.
15/05/26 Free

Director

2,379 0.0003%
15/05/26 Free

Director

2,379 0.0003%
15/05/26 Free

Director

2,379 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+1.20%+3.57%+5.01%-14.63% 142B
+0.72%+2.48%+29.16%+2.37% 199B
+2.97%-3.11%-22.21%+12.70% 138B
+4.66%-0.34%-56.55%-14.78% 63.97B
+0.54%-4.31%+14.78%-5.68% 50.25B
+1.18%+2.27%-23.75%-31.73% 44.33B
-0.05%+0.52%+18.39%+13.56% 38.05B
+0.69%-0.19%+30.00%+39.50% 36.81B
+2.32%-0.28%-14.49%-20.53% 28.75B
+1.84%-3.29%-20.71%-8.68% 28.64B
Average +1.54%-1.66%-4.04%-2.79% 76.96B
Weighted average by Cap. +1.57%-0.27%+0.41%-1.77%

Financials

2026 *2027 *
Net sales 26.11B 22.82B 21.11B 19.37B 36.65B 2,516B 37.29B 252B 98.87B 1,229B 98.05B 95.89B 4,241B 28.41B 24.83B 22.96B 21.07B 39.88B 2,737B 40.58B 274B 108B 1,337B 107B 104B 4,615B
Net income 4.42B 3.86B 3.57B 3.28B 6.2B 426B 6.31B 42.58B 16.73B 208B 16.59B 16.22B 718B 5.35B 4.67B 4.32B 3.97B 7.51B 515B 7.64B 51.56B 20.25B 252B 20.08B 19.64B 869B
Net Debt 22.11B 19.32B 17.87B 16.4B 31.03B 2,130B 31.57B 213B 83.72B 1,040B 83.01B 81.19B 3,591B 14.57B 12.73B 11.77B 10.8B 20.45B 1,404B 20.8B 140B 55.16B 685B 54.7B 53.5B 2,366B
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (40.5% of net sales); - life sciences equipment (29.8%); - biotechnology equipment (29.7%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (40.6%), China (10.7%) and other (48.7%).
Employees
59,000
Date Price Change Volume
16/07/26 US$202.96 +1.08% 2,453,955
15/07/26 US$200.79 +0.87% 4,373,205
14/07/26 US$199.05 -0.55% 4,188,554
13/07/26 US$200.16 +0.56% 2,918,894
10/07/26 US$199.05 +1.57% 3,847,652
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
200.79USD
Average target price
242.52USD
Spread / Average Target
+20.78%

Quarterly revenue - Rate of surprise